Working… Menu

Study of Intravenous ATYR1923 for Pulmonary Sarcoidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03824392
Recruitment Status : Completed
First Posted : January 31, 2019
Last Update Posted : July 22, 2021
Foundation for Sarcoidosis Research
Information provided by (Responsible Party):
aTyr Pharma, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 29, 2021
Actual Study Completion Date : June 29, 2021